|
Director
Diabetes Trials Unit
University of Oxford |
|
|
Rury Holman is the Director of the University of Oxford Diabetes Trials Unit and the first Professor of Diabetic Medicine to be appointed at the University of Oxford. He is Honorary Consultant Physician to the Oxford Radcliffe Hospitals NHS Trust and immediate past Academic Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM).
Professor Holman was a joint recipient of the 1999 ADA Charles H. Best Award, the Pfizer Visiting Professor at the University of Washington in 2002, gave the 2003 Royal College of Physicians Lord Rayner Memorial Lecture, was awarded the 2006 Helmutt Mehnert/Unesco/German Diabetes UNION Award, received the 2007 Outstanding Foreign Investigator Award from the Japan Society of Diabetic Complications, gave the 2008 Ricardo Fernando Professorial Lecture, the 2008 Diabetes UK Banting Memorial Lecture and the 2009 Toronto Diabetes Association Charles H. Best Lecture.
Professor Holman divides his time between clinical care of patients, teaching and his many research interests. He has designed and run many multicentre studies that focus primarily on the prevention, appropriate treatment and cardiovascular risk reduction in type 2 diabetes, and has published over 200 peer-reviewed manuscripts. Currently he is Co-chair of NAVIGATOR, Joint Chair of TECOS and EXSCEL, and Chief Investigator of the 4-T, ACE and UKPDS trials.
Conflicts of interest
Professor Holman has, in the last twelve months: received research support from Amylin, Bayer, Merck and Novartis; attended advisory boards with Amylin, Lilly, Merck, Novartis and Novo Nordisk; and given lectures supported by Bayer, Lilly, Merck and Merck Serono.
|
About the DTU
› Home page
Software
› HOMA Calculator
